Abstract: The present application relates to a method for producing a reassortant Reoviridae virus and a vector library for the same, and provides: a method for producing a reassortant Reoviridae virus by using a cell line into which an RNA polymerase is introduced and an expression vector library according to an aspect; a reassortant Reoviridae virus produced by the method; and an expression vector library for producing reassortant rotavirus.

Abstract: Provided is a concentration measuring apparatus, which measures a concentration of a fluid under a high-pressure environment, such as an environment in which a supercritical fluid is provided. The concentration measuring apparatus includes: a concentration meter for measuring a concentration of a first fluid contained in a fluid in the measurement line; a sampling line for transferring a process fluid of a processing space in which a substrate is treated in a high-pressure environment to the measurement line; a control valve for opening and closing the sampling line; a fluid pressure regulator installed downstream the control valve in the sampling line and configured to adjust the passing fluid to a set pressure; and a decompression tank installed between the sampling line and the measurement line.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: Proposed is a head for ultrasound therapy including an upper portion and a lower portion, wherein the upper portion includes a first axial movement portion moving in a back and forth direction, a second axial movement portion being connected to the first axial movement portion and moving the first axial movement portion in a left and right direction, a ball joint being connected to the first axial movement portion, and an ultrasound transducer portion that is connected to the ball joint and is moved by both the first axial movement portion as well as the second axial movement portion.

Abstract: Proposed is a head for ultrasound therapy including an upper portion and a lower portion, wherein the lower portion includes a space portion and an ultrasound transducer portion moving inside the space portion that is filled with a coolant.

Abstract: A beauty device with rollers is proposed. The beauty device with rollers includes a main body part held by a user in his/her hand, a pair of rotating body support parts, each of which has one end coupled to the main body part, the rotating body support parts having an angle ?1 therebetween in a V-shape, and a pair of rotating body units coupled to the pair of rotating body support parts respectively, the rotating body units being configured to be rotated to massage the skin, wherein each of the rotating body units includes a shaft part having a step and an inclined one side, a first bearing part inserted into the shaft part, a second bearing part inserted into the shaft part, a roller part rotatably coupled to each of the rotating body support parts, and a nut part having a through hole inside.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: A skin care device using an RF needle is disclosed. According to an embodiment, a skin contact part having a plurality of needles and a vacuum pressure formation unit for applying a suction force to the skin contact part are included, and thus a needle can be inserted into the skin by pulling the skin with vacuum pressure. Therefore, the skin is pulled with suction so that an equipment contact surface accurately comes into contact with the skin, and thus a needle can be correctly inserted into the inner layer of the skin.

Abstract: Proposed is a complex aqua skin peeling machine which allows for the use of a handpiece to supply hydrogen water to the skin of a user for removal of reactive oxygen species in the user's body.

Abstract: A skin treatment device is provided, which includes a needle frame in which a front end outlet of a needle that penetrates an inside thereof projects toward a front thereof, a rear end inlet of the needle is open to an outside of a rear surface thereof, and a stepped partition wall is provided in a closed shape on the outside of the rear surface thereof; a needle cover having a space portion formed on a rear thereof toward an inside thereof, a needle guide portion formed on a front surface thereof; a contact PCB configured to receive a power that is supplied from a power supply device; and a needle hub having an insertion portion formed in a front thereof toward an inside thereof.

Abstract: The present invention relates to a human antibody specifically binding to an acne-inducing bacterium using phage display technology and a use thereof, and more particularly, an antibody specifically binding to an antigen; a human antibody including the same; phage display technology using the same; and a cosmetic composition and a pharmaceutical composition using the same.

Abstract: A handpiece tip is proposed. The handpiece tip includes a contact part to contact the skin, and a coupling part having a space formed therein and coupled to a handpiece body, wherein the contact part includes a surface, a protruding part provided to protrude on an outer side of the surface and touching the skin, a discharging hole formed on the surface to discharge a therapeutic liquid, and a suctioning hole formed on the surface so as to suction a mixture of dead skin cells and the liquid. According to the disclosure, there are effects in that nutrient solution is injected by way of closely contacting the skin, the layers of dead skin cells are removed, and desired abrasive performance on the skin is realized while minimizing skin damage.

Abstract: The present invention relates to an antibody specifically binding to thioredoxin-1 and a use thereof, and more particularly, to an antibody specifically binding to thioredoxin-1 or an antigen-binding fragment thereof, a nucleic acid molecule(s) encoding a heavy chain and/or a light chain of the antibody or antigen-binding fragment thereof, a recombinant vector including the nucleic acid molecule, host cells, a method of preparing the antibody or antigen-binding fragment thereof, a breast cancer diagnostic kit, and a method of providing information necessary for breast cancer diagnosis.

Abstract: A backlight unit includes a first light guide plate, a second light guide plate disposed over the first light guide plate, and a first wavelength conversion layer disposed between the first light guide plate and the second light guide plate.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: A backlight unit includes a first optical member. The first optical member includes a protrusion extending from a surface of the first optical member. A mold frame partially surrounds the surface of the first optical member. The protrusion of the first optical member includes a fixing hole. The mold frame includes at least one fixing protrusion configured to be inserted into the fixing hole of the protrusion.

Abstract: The present invention relates to an antibody specifically binding to thioredoxin-1 and a use thereof, and more particularly, to an antibody specifically binding to thioredoxin-1 or an antigen-binding fragment thereof, a nucleic acid molecule(s) encoding a heavy chain and/or a light chain of the antibody or antigen-binding fragment thereof, a recombinant vector including the nucleic acid molecule, host cells, a method of preparing the antibody or antigen-binding fragment thereof, a breast cancer diagnostic kit, and a method of providing information necessary for breast cancer diagnosis.

Abstract: A backlight unit includes a first light guide plate, a second light guide plate disposed over the first light guide plate, and a first wavelength conversion layer disposed between the first light guide plate and the second light guide plate.

Abstract: The present invention relates to a human antibody specifically binding to an acne-inducing bacterium using phage display technology and a use thereof, and more particularly, an antibody specifically binding to an antigen; a human antibody including the same; phage display technology using the same; and a cosmetic composition and a pharmaceutical composition using the same.